[144] Teradyne, Inc. SEC Filing

Rhea-AI Filing Summary

Teradyne, Inc. (TER) filed a Form 144 indicating a planned routine insider sale.

• Securities: 554 common shares
• Estimated value: $58,574.42
• Broker: Fidelity Brokerage Services LLC
• Planned trade date: 30 Jul 2025
• Exchange: NASDAQ
• Shares outstanding: 160,420,287

The shares stem from a restricted-stock vesting that occurred on 27 Jan 2025 and will be sold for the account of an unnamed insider. The proposed sale represents <0.001% of shares outstanding, suggesting minimal dilution or market impact. No prior sales in the last three months were reported.

Insights

Corporate Governance Expert

TL;DR: Routine Form 144 for just 554 shares; immaterial governance impact.

Form 144 signals an insider’s intent to sell but does not guarantee execution. With only 554 shares relative to the 160 million outstanding, this filing is largely procedural. Lack of identity details limits insight into insider sentiment, yet the tiny fraction implies no governance red flag. No 10b5-1 plan date is provided, but the representation of no undisclosed adverse information is standard.

Portfolio Manager

TL;DR: Negligible portfolio relevance; size far too small to affect TER valuation.

The $58.6k proposed sale is de minimis versus Teradyne’s multi-billion-dollar market cap and daily trading volume. I view the event as non-impactful; no adjustment to position sizing or risk models is warranted. Absence of clustered insider selling or unusual timing further supports a neutral stance.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Fidelity Brokerage Services LLC 900 Salem Street Smithfield RI 02917	554	58574.42	160420287	07/30/2025	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	01/27/2025	Restricted Stock Vesting	Issuer			554	01/27/2025	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Nothing to Report

144: Remarks and Signature

Remarks

Date of Notice

Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

How many Teradyne (TER) shares are covered by this Form 144?

The filing covers 554 common shares.

What is the estimated market value of the shares to be sold?

The aggregate value disclosed is $58,574.42.

When is the proposed sale date for the TER shares?

The filer intends to sell on 30 July 2025.

What percentage of Teradyne’s outstanding shares does this sale represent?

Approximately 0.0003% (less than 0.001%) of the 160,420,287 shares outstanding.

What was the source of the shares being sold?

They were acquired via restricted-stock vesting on 27 Jan 2025.

Which broker will execute the sale?

The sale is slated through Fidelity Brokerage Services LLC.